Citalopram Production Cost Reports

The report provides a detailed analysis essential for establishing a Citalopram production plant. It encompasses all critical aspects necessary for Citalopram production, including the cost of Citalopram production, Citalopram plant cost, Citalopram production costs, and the overall Citalopram production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Citalopram production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Citalopram is a prescription medication mainly used to treat depression. It is primarily used as an antidepressant for the treatment of major depressive disorder and related mood conditions. It belongs to a group of drugs called selective serotonin reuptake inhibitors (SSRIs), which help increase the levels of serotonin in the brain to improve mood. It is also used to manage conditions like anxiety disorders, panic attacks, and obsessive-compulsive disorder (OCD). It is also sometimes used in the treatment of social anxiety and post-traumatic stress disorder (PTSD). It is often used off-label for treating premenstrual dysphoric disorder (PMDD) and eating disorders.

The demand for Citalopram is primarily driven by its application as a prescription medication for long-term mental health management, which strengthens its market expansion. Its application as an oral drug in the treatment of depression, anxiety disorders, and related mental health conditions also strongly supports its demand in the pharmaceutical and healthcare sectors.

Its application in managing conditions such as panic disorder, obsessive-compulsive disorder (OCD), and premenstrual dysphoric disorder (PMDD) further adds to its demand in the medical sector. The increasing global awareness of mental health, along with rising diagnosis rates and improved access to psychiatric care, continues to boost the market for antidepressant medications like Citalopram. Industrial Citalopram procurement is influenced by factors such as the availability and cost of active pharmaceutical ingredients (APIs), adherence to regulatory standards, production efficiency, and the implementation of sustainable production methods. Supplier consistency, quality control, and advancements in formulation technology also play a crucial role in shaping procurement processes across regions.

Raw Material for Citalopram Production

According to the Citalopram production plant project report, the major raw materials for Citalopram production include p-Bromochlorobenzene, Magnesium, 5-bromophthalide, 3-dimethylaminopropylmagnesium chloride, and Hot Phosphoric Acid.

Production Process of Citalopram

The extensive Citalopram production cost report consists of the following industrial production process:

1. Production via Chemical Synthesis: The production process of Citalopram begins with the reaction of p-bromochlorobenzene with magnesium to form the corresponding Grignard reagent, which is then reacted with 5-bromophthalide to produce 4'-chloro-4-bromo-2-(hydroxymethyl)benzophenone. Further, this intermediate is treated with another Grignard reagent, 3-dimethylaminopropylmagnesium chloride, which results in the formation of alpha-(3-dimethylaminopropyl)-alpha-(p-chlorophenyl)-alpha-(4-bromo-2-hydroxymethyl)benzyl alcohol. Cyclisation of this compound under hot phosphoric acid conditions forms 5-bromophthalan, which undergoes a final transformation where the bromine atom is replaced with a cyano group using copper cyanide. Then, the reaction product is converted into its hydrobromide salt form to obtain Citalopram hydrobromide as the final product.

Citalopram is a selective serotonin reuptake inhibitor belonging to the class of bicyclic phthalane derivative antidepressants used primarily for the treatment of major depressive disorder. The compound appears as a white to off-white crystalline powder in its hydrobromide salt form, which is the most commonly used pharmaceutical formulation. The molecular formula of citalopram free base is C20H21FN2O, and its molecular mass is 324.4 g/mol. The melting point of citalopram hydrobromide is approximately 182-188 degree Celsius, and the free base exists as an oil with a boiling point of 175-181 degree Celsius at reduced pressure. The hydrobromide salt is sparingly soluble in water and ethanol but freely soluble in chloroform and readily dissolves in DMSO. The compound should be stored at controlled room temperature and taken orally with or without food. Citalopram may cause dose-dependent QT interval prolongation and carries a boxed warning regarding increased risk of suicidal thoughts and behaviours in pediatric and young adult patients. Therefore, requires careful monitoring during treatment initiation and dose adjustments.